Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and QuidelOrtho (QDEL)
RBC Capital Sticks to Their Buy Rating for QuidelOrtho (QDEL)
QuidelOrtho Raised to Buy From Neutral by Citigroup
Citi Upgrades QuidelOrtho(QDEL.US) to Buy Rating, Raises Target Price to $50
RBC Capital Sticks to Their Buy Rating for QuidelOrtho (QDEL)
QuidelOrtho Initiated at Hold by Jefferies
QuidelOrtho Analyst Ratings
Jefferies Initiates QuidelOrtho(QDEL.US) With Hold Rating, Announces Target Price $43
Craig-Hallum Upgrades QuidelOrtho(QDEL.US) to Buy Rating, Raises Target Price to $60
J.P. Morgan Maintains QuidelOrtho(QDEL.US) With Sell Rating, Maintains Target Price $38
RBC Capital Maintains QuidelOrtho(QDEL.US) With Buy Rating, Raises Target Price to $64
RBC Capital Sticks to Its Buy Rating for QuidelOrtho (QDEL)
RBC Capital Maintains QuidelOrtho(QDEL.US) With Buy Rating, Raises Target Price to $62
RBC Capital Reaffirms Their Buy Rating on QuidelOrtho (QDEL)
QuidelOrtho Raised to Neutral From Sell by UBS
RBC Lifts Price Target on QuidelOrtho to $62 From $61, Keeps Outperform Rating
QuidelOrtho Analyst Ratings
Craig-Hallum Upgrades QuidelOrtho(QDEL.US) to Buy Rating, Raises Target Price to $57
QuidelOrtho Analyst Ratings
RBC Capital Maintains QuidelOrtho(QDEL.US) With Buy Rating, Maintains Target Price $61